Literature DB >> 21410601

Role of neuronal nitric oxide synthase in colonic distension-induced hyperalgesia in distal colon of neonatal maternal separated male rats.

Y-W Tjong1, S-P Ip, L Lao, J Wu, H H S Fong, J J Y Sung, B Berman, C-T Che.   

Abstract

BACKGROUND: Nitric oxide (NO) is implicated in the pathogenesis of irritable bowel syndrome (IBS) but the underlying mechanism is unclear. Thus, the aim of the present study is to examine the role of NO synthase (NOS) expression in the distal colon of neonatal maternal separation (NMS) model rats employed in IBS studies.
METHODS: Male neonates of Sprague-Dawley rats were randomly assigned into NMS and normal control (N) groups. Rats of NMS group were subjected to 3 h daily maternal separation on postnatal day 2-21. Rats were administrated non-selective NOS inhibitor l-NAME (100 mg kg(-1) ), selective neuronal NOS (nNOS) inhibitor 7-NINA (10mgkg(-1) ), selective inducible NOS (iNOS) inhibitor, endothelial NOS (eNOS) inhibitor (10mgkg(-1) ) or Vehicle (Veh; distilled water) intraperitoneally 1h prior to the experiment for the test and control groups, respectively. KEY
RESULTS: The amount of NO was significantly higher in the NMS Veh rats compared with unseparated N rats. Western-blotting and real-time quantitative PCR studies showed that protein and mRNA expression of nNOS were higher in the NMS group than that in the N rats; whereas no significant change in iNOS and eNOS was found in either groups. Neonatal maternal separation Veh rats showed low pain threshold and increased electromyogram (EMG) activity in response to colonic distension stimuli. l-NAME and 7-Nitroindazole monosodium salt (7-NINA) increased pain threshold pressure and attenuated EMG activity in the NMS rats. In addition, l-NAME and 7-NINA substantially reduced oxidative marker malondialdehyde level in NMS rats. CONCLUSIONS & INFERENCES: Neonatal maternal separation increased the NO generation by nNOS upregulation that interact with reactive oxygen species contributing to the visceral hypersensitivity in IBS.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21410601      PMCID: PMC3117987          DOI: 10.1111/j.1365-2982.2011.01697.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  46 in total

1.  The putative role of inflammation in the irritable bowel syndrome.

Authors:  S M Collins; T Piche; P Rampal
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Nitric oxide in inflammatory bowel disease.

Authors:  Raymond K Cross; Keith T Wilson
Journal:  Inflamm Bowel Dis       Date:  2003-05       Impact factor: 5.325

4.  Site-specific gene expression of nNOS variants in distinct functional regions of rat gastrointestinal tract.

Authors:  Dieter Saur; Winfried L Neuhuber; Bernd Gengenbach; Andrea Huber; Volker Schusdziarra; Hans-Dieter Allescher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-02       Impact factor: 4.052

Review 5.  Novel effects of nitric oxide.

Authors:  K L Davis; E Martin; I V Turko; F Murad
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

Review 6.  Maternal separation as a model of brain-gut axis dysfunction.

Authors:  Siobhain M O'Mahony; Niall P Hyland; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2010-10-01       Impact factor: 4.530

7.  Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome.

Authors:  T Piche; P Ducrotté; J M Sabate; B Coffin; F Zerbib; M Dapoigny; M Hua; E Marine-Barjoan; R Dainese; X Hébuterne
Journal:  Neurogastroenterol Motil       Date:  2010-04-19       Impact factor: 3.598

Review 8.  Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment.

Authors:  Joseph Y Chang; Nicholas J Talley
Journal:  Trends Pharmacol Sci       Date:  2010-06-01       Impact factor: 14.819

9.  Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice.

Authors:  B M R Spiegel; R Bolus; L A Harris; S Lucak; W D Chey; G Sayuk; E Esrailian; A Lembo; H Karsan; K Tillisch; J Talley; L Chang
Journal:  Aliment Pharmacol Ther       Date:  2010-08-30       Impact factor: 8.171

10.  Role of oxidative stress in animal model of visceral pain.

Authors:  Simon Vaculin; Miloslav Franek; Martin Vejrazka
Journal:  Neurosci Lett       Date:  2010-04-24       Impact factor: 3.046

View more
  9 in total

Review 1.  Nitric oxide in the gastrointestinal tract: opportunities for drug development.

Authors:  John L Wallace
Journal:  Br J Pharmacol       Date:  2018-12-03       Impact factor: 8.739

2.  Neuronal Nitric Oxide Synthase Is a Novel Biomarker for the Interstitial Cells of Cajal in Stress-Induced Diarrhea-Dominant Irritable Bowel Syndrome.

Authors:  Da Eun Jang; Ji Hyun Bae; Yoo Jin Chang; Yoon Hoo Lee; Ki Taek Nam; Il Yong Kim; Je Kyung Seong; Yong Chan Lee; Su Cheong Yeom
Journal:  Dig Dis Sci       Date:  2018-01-25       Impact factor: 3.199

3.  Positive Correlation between nNOS and Stress-Activated Bowel Motility Is Confirmed by In Vivo HiBiT System.

Authors:  Jeong Pil Han; Jeong Hyeon Lee; Geon Seong Lee; Ok Jae Koo; Su Cheong Yeom
Journal:  Cells       Date:  2021-04-27       Impact factor: 6.600

4.  Alpha-lipoic Acid suppresses P2X receptor activities and visceral hypersensitivity to colorectal distention in diabetic rats.

Authors:  Ji Hu; Xin Qin; Zhen-Yuan Song; Pan-Pan Yang; Yu Feng; Qian Sun; Guang-Yin Xu; Hong-Hong Zhang
Journal:  Sci Rep       Date:  2017-06-28       Impact factor: 4.379

5.  Maternal Separation Induced Visceral Hypersensitivity from Childhood to Adulthood.

Authors:  Lisha Yi; Haiqin Zhang; Huihui Sun; Lu Zhou; Ying Chen; Liqian Xuan; Yuanxi Jiang; Shuchang Xu
Journal:  J Neurogastroenterol Motil       Date:  2017-04-30       Impact factor: 4.924

6.  Nesfatin-1 in the dorsal raphe nucleus influences visceral sensitivity via 5-HT neurons in male maternally separated rats.

Authors:  Hui-Ai Zhang; Nan Sang; Xian Ge; Qian Huang; Xue-Liang Li; Jie Sha
Journal:  Sci Rep       Date:  2018-06-19       Impact factor: 4.379

7.  Activating metabotropic glutamate receptor‑7 attenuates visceral hypersensitivity in neonatal maternally separated rats.

Authors:  Limei Shao; Yanbing Liu; Junhua Xiao; Qunying Wang; Fei Liu; Jin Ding
Journal:  Int J Mol Med       Date:  2018-12-11       Impact factor: 4.101

8.  Melanin-concentrating hormone promotes anxiety and intestinal dysfunction via basolateral amygdala in mice.

Authors:  Xiaoman He; Yuhang Li; Nana Zhang; Jinfang Huang; Xing Ming; Ruixiao Guo; Yang Hu; Pengfei Ji; Feifei Guo
Journal:  Front Pharmacol       Date:  2022-08-09       Impact factor: 5.988

9.  Effect of nitrergic system on colonic motility in a rat model of irritable bowel syndrome.

Authors:  Tijen Kaya Temiz; Omer Demir; Fatma Simsek; Yusuf Cem Kaplan; Selen Bahceci; Barıs Karadas; Aslı Celik; Gokhan Koyluoglu
Journal:  Indian J Pharmacol       Date:  2016 Jul-Aug       Impact factor: 1.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.